RAF1 and osteosarcoma: These results implied that tomatidine’s inhibition of invasion and migration in human osteosarcoma U2OS and HOS cells resulted from the attenuation of PS-1 and the c-Raf–MEK–ERK pathway, rather than JNK, p38, and PI3K-Akt signaling.